How Dr. Jill Carnahan Uses Peptides for Mold, MCAS, and Chronic Illness
1 month ago
- Understand why many people remain sick even after mold remediation by uncovering hidden environmental exposures, lingering mycotoxins, and immune system dysfunction that continue driving symptoms.
- Discover how peptides such as BPC-157, KPV, thymosin alpha-1, mitochondrial peptides, and low-dose GLP-1 therapies are being used to support recovery in patients with mold illness, MCAS, chronic fatigue, and inflammation.
- Learn why healing must be paced carefully and how aggressively pushing detoxification, mitochondrial function, or methylation can trigger worsening symptoms when the body is not ready to eliminate toxins efficiently.
Comments